[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 5027 followers Created: 2025-07-20 18:06:05 UTC 🦉 Use of SGLT2i lower in women than men (50.2% vs. 59.9%, p < 0.001). In women with CKD, use was XXXX% vs. XXXX% in men (p = 0.04), suggesting a sex-based treatment gap in nephroprotection. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF  XX engagements  **Related Topics** [sny](/topic/sny) [manat](/topic/manat) [$zldpf](/topic/$zldpf) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [$sny](/topic/$sny) [$lly](/topic/$lly) [women](/topic/women) [Post Link](https://x.com/AponiaAnalytics/status/1946995040040911349)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 5027 followers
Created: 2025-07-20 18:06:05 UTC
🦉 Use of SGLT2i lower in women than men (50.2% vs. 59.9%, p < 0.001). In women with CKD, use was XXXX% vs. XXXX% in men (p = 0.04), suggesting a sex-based treatment gap in nephroprotection.
#diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF
XX engagements
/post/tweet::1946995040040911349